ArticleMolecular cancer therapeutics2019

Fenretinide via NOXA Induction, Enhanced Activity of the BCL-2 Inhibitor Venetoclax in High BCL-2-Expressing Neuroblastoma Preclinical Models.

Thinh H Nguyen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.